Elevated TAK1 augments tumor growth and metastatic capacities of ovarian cancer cells through activation of NF-κB signaling.
about
Identification of therapeutic targets applicable to clinical strategies in ovarian cancerTGFβ-activated Kinase 1 (TAK1) Inhibition by 5Z-7-Oxozeaenol Attenuates Early Brain Injury after Experimental Subarachnoid HemorrhageMUC1-C activates the TAK1 inflammatory pathway in colon cancerThe role of TAK1 expression in thyroid cancer.Nuclear HDAC6 inhibits invasion by suppressing NF-κB/MMP2 and is inversely correlated with metastasis of non-small cell lung cancer.Targeting AMPK signaling in combating ovarian cancers: opportunities and challenges.NSAID-activated gene 1 mediates pro-inflammatory signaling activation and paclitaxel chemoresistance in type I human epithelial ovarian cancer stem-like cells.Expression and function of transforming growth factor‑β‑activated protein kinase 1 in gastric cancer.Studies of TAK1-centered polypharmacology with novel covalent TAK1 inhibitors.Inhibition of ovarian cancer cell growth by a novel TAK1 inhibitor LYTAK1.The long non-coding RNA, SNHG6-003, functions as a competing endogenous RNA to promote the progression of hepatocellular carcinoma.Structure-guided development of covalent TAK1 inhibitors.GRO-α and IL-8 enhance ovarian cancer metastatic potential via the CXCR2-mediated TAK1/NFκB signaling cascade.
P2860
Q28829029-CE411136-7702-4B79-8407-091CCEE79E10Q35925884-5FF12DBC-28B3-4E0A-939F-BCF0F36D3759Q35931767-2E323CEE-4E89-4FBE-A99C-1216651909C8Q36464451-78900BEB-E46A-4B49-A1B9-EFC1DA9ABF08Q36557560-6FB9BE06-F35F-41BE-826F-0EAC7C0A405FQ36949580-EBE1B227-17E6-472B-902A-BF0973D4BCC7Q37687793-241A41F1-EC3C-4AF8-9C5B-9BD2F4CDAA9FQ38656687-973D1390-3948-426B-B254-1B4CA9641A9AQ38723513-9E4E9656-D47C-4769-B148-9FDB92BC08E6Q38847653-878067C2-C542-4EE2-96E0-CF71FCDD4119Q40573712-B4BD1D64-6ED6-4C3D-98D9-609EBC5DA74EQ49726907-FE23E11C-8997-4BA3-AD3D-BAD0B1E6E1FBQ52430611-7F012601-0F1D-4B0A-B6AA-EE878032E5EE
P2860
Elevated TAK1 augments tumor growth and metastatic capacities of ovarian cancer cells through activation of NF-κB signaling.
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Elevated TAK1 augments tumor g ...... activation of NF-κB signaling.
@ast
Elevated TAK1 augments tumor g ...... activation of NF-κB signaling.
@en
Elevated TAK1 augments tumor g ...... activation of NF-κB signaling.
@nl
type
label
Elevated TAK1 augments tumor g ...... activation of NF-κB signaling.
@ast
Elevated TAK1 augments tumor g ...... activation of NF-κB signaling.
@en
Elevated TAK1 augments tumor g ...... activation of NF-κB signaling.
@nl
prefLabel
Elevated TAK1 augments tumor g ...... activation of NF-κB signaling.
@ast
Elevated TAK1 augments tumor g ...... activation of NF-κB signaling.
@en
Elevated TAK1 augments tumor g ...... activation of NF-κB signaling.
@nl
P2093
P2860
P356
P1433
P1476
Elevated TAK1 augments tumor g ...... activation of NF-κB signaling
@en
P2093
David W Chan
Hermit W M Tang
Iris J Liu
Karen K L Chan
Kwok-Ming Yao
Patty C H Cai
Thomas H Y Leung
Vincent W S Liu
P2860
P304
P356
10.18632/ONCOTARGET.2273
P407
P577
2014-09-01T00:00:00Z